- Report
- October 2024
- 197 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- April 2025
- 173 Pages
Global
From €5324EUR$5,850USD£4,564GBP
- Report
- July 2024
- 144 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- May 2024
- 180 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- February 2024
- 110 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- March 2024
- 150 Pages
Global
From €4414EUR$4,850USD£3,784GBP
- Report
- December 2023
- 172 Pages
Global
€4546EUR$4,995USD£3,897GBP
- Report
- October 2024
- 100 Pages
Global
From €3500EUR$4,120USD£3,106GBP
The Arbovirus Testing market is a subset of the larger Infectious Disease Testing market. It is focused on the detection of arboviruses, which are a group of viruses transmitted by arthropods such as mosquitoes, ticks, and sandflies. These viruses can cause a range of illnesses, including dengue, chikungunya, Zika, and yellow fever. Arbovirus Testing is used to diagnose and monitor these diseases, as well as to track the spread of arboviruses in a given population.
Arbovirus Testing is typically performed using molecular techniques such as PCR and RT-PCR, as well as serological methods such as ELISA and immunofluorescence. These tests are available from a variety of companies, including Abbott, Bio-Rad, Cepheid, DiaSorin, Hologic, and Roche. Show Less Read more